Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients

Annals of Neurology

Volumn 38, Issue 4, 1995, Pages 580-588

  Remy, Philippe ^a   Samson, Yves ^a   Hantraye, Philippe ^a,b   Fontaine, Anne ^a   Defer, Gilles ^c,e   Mangin, Jean‐François ^a   Fénelon, Gilles ^f   Gény, Christian ^c,e   Ricolfi, Frédéric ^a,e   Frouin, Vincent ^a   N'Guyen, Jean‐Paul ^d,e   Jeny, Roland ^g   Degos, Jean‐Denis ^c   Peschanski, Marc ^e   Cesaro, Pierre ^c,e  

^a HENRI MONDOR HOSPITAL   (France)

^b CNRS   (France)

^c Service de Neurologie   (France)

^d Service de Neurochirurgie   (France)

^e INSERM   (France)

^f HÔPITAL TENON   (France)

^g Hopital Esquirol   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FLUORODOPA F 18; GERMANIUM; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CELL TRANSPLANTATION; CLINICAL ARTICLE; DRUG UPTAKE; FETUS; FETUS CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FETAL TISSUE TRANSPLANTATION; METABOLISM; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING;

BRAIN; DIHYDROXYPHENYLALANINE; FETAL TISSUE TRANSPLANTATION; FLUORINE RADIOISOTOPES; GRAFT SURVIVAL; HUMAN; MAGNETIC RESONANCE IMAGING; MIDDLE AGE; PARKINSON DISEASE; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0028991533     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410380406     Document Type: Article

References (25)

1. Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries
2. Neural transplantation: an experimental tool with clinical possibilities
3. Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials
4. Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's disease
5. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
6. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
7. Bilateral motor improvement and alteration of l‐Dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of fetal ventral mesencephalon
8. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease
9. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease
10. Functional imaging in relation to parkinsonian syndromes
11. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET
12. 18F]fluorodopa studies correlate with dopamine cell counts and levels
13. The role of positron emission tomography in the assessment of human neurotransplantation
14. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and 6‐month follow‐up
15. PET studies of parkinsonian patients treated with autologous adrenal implants
16. Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role?
17. Core assessment program for intracerebral transplantations (CAPIT)
18. Physical characteristics of the ECAT 953B/31: a new high resolution brain positron tomograph
19. Fast nonsupervised 3D registration of PET and MR images of the brain
20. Peduncular ‘rubral’ tremor and dopaminergic denervation: a PET study
21. Graphical evaluation of blood‐to‐brain transfer constants from multiple‐time uptake data. Generalizations
22. 18F]fluoro‐l‐dopa in Parkinson's disease measured with positron emission tomography
23. 18F]6‐l‐fluorodopa studies in two patients with putaminal implants
24. Long‐term delayed vascularization of human neural transplants to the rat brain